LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.

SEHK:2291 Stock Report

Market Cap: HK$8.1b

LEPU ScienTech Medical Technology (Shanghai) Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Juan Chen

Chief executive officer

CN¥4.8m

Total compensation

CEO salary percentage34.3%
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure3yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital

Mar 03
LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital

The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence

Nov 09
The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit

Aug 14
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit

CEO Compensation Analysis

How has Juan Chen's remuneration changed compared to LEPU ScienTech Medical Technology (Shanghai)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CN¥5mCN¥2m

CN¥152m

Sep 30 2023n/an/a

CN¥92m

Jun 30 2023n/an/a

CN¥32m

Mar 31 2023n/an/a

CN¥6m

Dec 31 2022CN¥5mCN¥2m

-CN¥20m

Sep 30 2022n/an/a

CN¥11m

Jun 30 2022n/an/a

CN¥41m

Mar 31 2022n/an/a

CN¥50m

Dec 31 2021CN¥4mCN¥1m

CN¥59m

Dec 31 2020CN¥684kCN¥620k

CN¥69m

Dec 31 2019CN¥677kCN¥577k

CN¥52m

Compensation vs Market: Juan's total compensation ($USD656.88K) is above average for companies of similar size in the Hong Kong market ($USD482.33K).

Compensation vs Earnings: Juan's compensation has been consistent with company performance over the past year.


CEO

Juan Chen (51 yo)

3.3yrs

Tenure

CN¥4,754,000

Compensation

Ms. Juan Chen has been Executive Chairman and General Manager of Lepu Scientech Medical Technology (Shanghai) Co., Ltd since January 29, 2021. She joined Lepu Scientech Medical Technology (Shanghai) Co., L...


Leadership Team

NamePositionTenureCompensationOwnership
Juan Chen
Executive Chairman & GM3.3yrsCN¥4.75mno data
Xue Qin
Deputy GM3yrsno datano data
Yufeng He
Deputy GM & COO3yrsno datano data
Xiani Zhang
Deputy General Manager3yrsno datano data
Kejin Qiu
Head of Research & Development of Valve Divisionless than a yearno datano data
Jinpeng Hu
Head of Research and Development of Occluder Divisionless than a yearno datano data
Mei Ying Ko
Joint Company Secretaryless than a yearno datano data

3.0yrs

Average Tenure

39.5yo

Average Age

Experienced Management: 2291's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Juan Chen
Executive Chairman & GM3.3yrsCN¥4.75mno data
Daozhi Liu
Independent Non-Executive Director2.9yrsCN¥211.00kno data
Shan Fu
Non-Executive Director2.9yrsno datano data
Ka Lai Chan
Independent Non-Executive Director2.7yrsCN¥200.00kno data
Xinglin Wang
Supervisor3.3yrsno datano data
Guorui Zheng
Non-Executive Director2.9yrsno datano data
Yuxin Zhang
Non-Executive Directorless than a yearCN¥3.69mno data
Yufeng Zheng
Independent Non-Executive Director2.9yrsCN¥200.00kno data
Xiaoyong Wang
Supervisor3.3yrsno datano data
Weidong Qian
Employee Representative Supervisor2.9yrsno datano data

2.9yrs

Average Tenure

50.5yo

Average Age

Experienced Board: 2291's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.